• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为新冠疫情制定外部质量评估的挑战。

The challenge of producing an EQA for the COVID-19 pandemic.

作者信息

Badrick Tony, Wienholt Louise, Fone Daniel, Holzhauser Derek

机构信息

The Royal College of Pathologists of Australasia Quality Assurance Programs, St Leonards, Sydney, Australia.

出版信息

Pract Lab Med. 2020 Nov;22:e00179. doi: 10.1016/j.plabm.2020.e00179. Epub 2020 Oct 17.

DOI:10.1016/j.plabm.2020.e00179
PMID:33102672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568490/
Abstract

The COVID-19 pandemic has changed the clinical medicine landscape. The importance of pathology testing has come to the forefront. Patients or potential patients are dealing directly with laboratories as they line up in carparks or testing staff come to the front doors to obtain samples. Laboratories have had to increase capacity to deal with the high volumes of testing driven by the need to identify and quarantine cases. Supporting this effort, External Quality Assurance scheme providers have also needed to produce COVID-19 Proficiency Testing (PT) programs which are fit for purpose. COVID-19 Point of Care testing has become critical frontline testing and has required the PT programs to be simple to use, readily accessible and robust. We describe a COVID-19 PoCT Serology PT program supported by a mobile phone App. The App is described, and the advantages made explicit. This App suggests that the way that PoCT EQA/PT programs may be deployed in the future.

摘要

新冠疫情改变了临床医学格局。病理学检测的重要性已成为焦点。患者或潜在患者在停车场排队时直接与实验室打交道,或者检测人员到前门获取样本。由于需要识别和隔离病例,实验室不得不提高检测能力以应对大量检测需求。为支持这一工作,外部质量保证计划提供商也需要制定适用于新冠病毒的能力验证(PT)计划。新冠即时检测已成为关键的一线检测手段,这就要求PT计划使用简便、易于获取且可靠。我们描述了一个由手机应用程序支持的新冠即时检测血清学PT计划。文中介绍了该应用程序,并明确了其优势。此应用程序表明了未来即时检测EQA/PT计划的部署方式。

相似文献

1
The challenge of producing an EQA for the COVID-19 pandemic.为新冠疫情制定外部质量评估的挑战。
Pract Lab Med. 2020 Nov;22:e00179. doi: 10.1016/j.plabm.2020.e00179. Epub 2020 Oct 17.
2
External quality assessment: best practice.外部质量评估:最佳实践。
J Clin Pathol. 2014 Aug;67(8):651-5. doi: 10.1136/jclinpath-2013-201621. Epub 2014 Mar 12.
3
Inter-Laboratory Comparisons and EQA in the Mediterranean Area.地中海地区的实验室间比对和室间质量评价
EJIFCC. 2018 Dec 5;29(4):253-258. eCollection 2018 Dec.
4
Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics.分子遗传学中能力验证和外部质量评估的现状和新范式。
Arch Pathol Lab Med. 2013 Jul;137(7):983-8. doi: 10.5858/arpa.2012-0311-RA.
5
Proficiency testing/external quality assessment: current challenges and future directions.能力验证/外部质量评估:当前的挑战和未来的方向。
Clin Chem. 2011 Dec;57(12):1670-80. doi: 10.1373/clinchem.2011.168641. Epub 2011 Sep 30.
6
Quality assuring HIV point of care testing using whole blood samples.使用全血样本确保HIV即时检测的质量
Pathology. 2016 Aug;48(5):498-500. doi: 10.1016/j.pathol.2016.04.005. Epub 2016 Jun 13.
7
Quality assurance for HIV point-of-care testing and treatment monitoring assays.HIV即时检测及治疗监测检测的质量保证
Afr J Lab Med. 2016 Oct 17;5(2):557. doi: 10.4102/ajlm.v5i2.557. eCollection 2016.
8
Essential aspects of external quality assurance for point-of-care testing.即时检验的外部质量保证的基本要素。
Biochem Med (Zagreb). 2017 Feb 15;27(1):81-85. doi: 10.11613/BM.2017.010.
9
External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe.欧洲即时凝血酶原时间(INR)检测的外部质量评估。
Clin Chem Lab Med. 2011 Sep 26;50(1):81-8. doi: 10.1515/CCLM.2011.719.
10
European consensus conference for external quality assessment in molecular pathology.欧洲分子病理学外部质量评估共识会议。
Ann Oncol. 2013 Aug;24(8):1958-63. doi: 10.1093/annonc/mdt153. Epub 2013 Apr 23.

引用本文的文献

1
Ensuring diagnostic testing accuracy for patient care and public health- COVID-19 testing scale-up from an EQA provider's perspective.从外部质量评估提供者的角度确保用于患者护理和公共卫生的诊断检测准确性——COVID-19检测的扩大规模
PLOS Glob Public Health. 2023 Dec 6;3(12):e0001615. doi: 10.1371/journal.pgph.0001615. eCollection 2023.
2
Assessment of COVID-19 Molecular Testing Capacity in Jordan: A Cross-Sectional Study at the Country Level.约旦新冠病毒分子检测能力评估:一项国家级横断面研究
Diagnostics (Basel). 2022 Apr 6;12(4):909. doi: 10.3390/diagnostics12040909.
3
COVID-19 Serology Control Panel Using the Dried-Tube Specimen Method.COVID-19 血清学控制检测盘,使用干试管样本检测法。
Am J Trop Med Hyg. 2022 Jan 7;106(2):562-565. doi: 10.4269/ajtmh.21-1036.

本文引用的文献

1
Serological tests for COVID-19.新型冠状病毒肺炎的血清学检测
Med J Aust. 2020 Nov;213(9):397-399.e1. doi: 10.5694/mja2.50766. Epub 2020 Sep 6.
2
Practical challenges related to point of care testing.与即时检测相关的实际挑战。
Pract Lab Med. 2015 Dec 9;4:22-29. doi: 10.1016/j.plabm.2015.12.002. eCollection 2016 Apr 1.
3
The Evidence to Support Point-of-Care Testing.支持即时检验的证据。
Clin Biochem Rev. 2010 Aug;31(3):111-9.
4
Does POCT reduce the risk of error in laboratory testing?即时检验(POCT)能否降低实验室检测中的错误风险?
Clin Chim Acta. 2009 Jun;404(1):59-64. doi: 10.1016/j.cca.2009.03.014. Epub 2009 Mar 17.
5
Point of care testing in Critical Care Medicine: the clinician's view.重症医学中的即时检验:临床医生的观点。
Clin Chim Acta. 2001 May;307(1-2):3-7. doi: 10.1016/s0009-8981(01)00448-x.